TFOS Lifestyle - Evidence quality report: Advancing the evaluation and synthesis of research evidence
- PMID: 37054912
- PMCID: PMC11246749
- DOI: 10.1016/j.jtos.2023.04.009
TFOS Lifestyle - Evidence quality report: Advancing the evaluation and synthesis of research evidence
Abstract
Evidence-based practice is a dominant paradigm in healthcare that emphasizes the importance of ensuring the translation of the best available, relevant research evidence into practice. An Evidence Quality Subcommittee was established to provide specialized methodological support and expertise to promote rigorous and evidence-based approaches for the Tear Film and Ocular Surface Society (TFOS) Lifestyle Epidemic reports. The present report describes the purpose, scope, and activity of the Evidence Quality Subcommittee in the undertaking of high-quality narrative-style literature reviews, and leading prospectively registered, reliable systematic reviews of high priority research questions, using standardized methods for each topic area report. Identification of predominantly low or very low certainty evidence across the eight systematic reviews highlights a need for further research to define the efficacy and/or safety of specific lifestyle interventions on the ocular surface, and to clarify relationships between certain lifestyle factors and ocular surface disease. To support the citation of reliable systematic review evidence in the narrative review sections of each report, the Evidence Quality Subcommittee curated topic-specific systematic review databases and relevant systematic reviews underwent standardized reliability assessment. Inconsistent methodological rigor was noted in the published systematic review literature, emphasizing the importance of internal validity assessment. Based on the experience of implementing the Evidence Quality Subcommittee, this report makes suggestions for incorporation of such initiatives in future international taskforces and working groups. Content areas broadly relevant to the activity of the Evidence Quality Subcommittee, including the critical appraisal of research, clinical evidence hierarchies (levels of evidence), and risk of bias assessment, are also outlined.
Keywords: AMSTAR; Cochrane; Critical appraisal; Evidence hierarchy; Evidence synthesis; Evidence-based practice; Meta-analysis; Ocular surface; Risk of bias; Systematic review.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest Laura E. Downie: Alcon (F), Azura Ophthalmics (F), BCLA (R), CooperVision (F), Cornea and Contact Lens Society of Australia (R), Medmont International (R), NHMRC Australia (F), Novartis (F), TFOS (S); Alexis Ceecee Britten-Jones: Plano (R); Ruth E Hogg: None; Isabelle Jalbert: Johnson & Johnson Vision (F), Diabetes Australia (F); Specsavers (R), University of Melbourne (R), Australian College of Optometry (R), Optometry Council of Australia and New Zealand (S), New South Wales Optometry Council (S); Tianjing Li: National Eye Institute, National Institutes of Health (F); Gareth Lingham: None; Su-Hsun Liu: None; Riaz Qureshi: None; Ian J Saldanha: None; Sumeer Singh: None; Jennifer P Craig: Adelphi Values Ltd (R), Alcon (F,R,C), Asta Supreme (R), Azura Ophthalmics (F,R), E-Swin (F,R), Johnson & Johnson Vision (R), Laboratoires Théa (F,R), Manuka Health NZ (F), Medmont International (R), Novoxel (R), Oculeve (F), Photon Therapeutics (R), Resono Ophthalmic (F,R), TFOS (S), Topcon (F,R), TRG Natural Pharmaceuticals (F,R).
Figures



Similar articles
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881. Med J Aust. 2020. PMID: 33314144
-
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001. JBI Libr Syst Rev. 2009. PMID: 27820426
-
TFOS Lifestyle Report Executive Summary: A Lifestyle Epidemic - Ocular Surface Disease.Ocul Surf. 2023 Oct;30:240-253. doi: 10.1016/j.jtos.2023.08.009. Epub 2023 Sep 1. Ocul Surf. 2023. PMID: 37659474 Review.
-
Digital Biomarker-Based Interventions: Systematic Review of Systematic Reviews.J Med Internet Res. 2022 Dec 21;24(12):e41042. doi: 10.2196/41042. J Med Internet Res. 2022. PMID: 36542427 Free PMC article.
Cited by
-
Intense Pulsed Light Therapy for Dry Eye Disease: Analyzing Temporal Changes in Tear Film Stability and Ocular Surface between IPL Sessions.Healthcare (Basel). 2024 May 30;12(11):1119. doi: 10.3390/healthcare12111119. Healthcare (Basel). 2024. PMID: 38891194 Free PMC article.
-
TFOS lifestyle: Impact of societal challenges on the ocular surface.Ocul Surf. 2023 Apr;28:165-199. doi: 10.1016/j.jtos.2023.04.006. Epub 2023 Apr 14. Ocul Surf. 2023. PMID: 37062429 Free PMC article.
-
TFOS Lifestyle: Impact of cosmetics on the ocular surface.Ocul Surf. 2023 Jul;29:77-130. doi: 10.1016/j.jtos.2023.04.005. Epub 2023 Apr 13. Ocul Surf. 2023. PMID: 37061220 Free PMC article.
References
-
- Craig JP, Nelson JD, Azar DT, Belmonte C, Bron AJ, Chauhan SK, et al. TFOS DEWS II report executive summary. Ocul Surf 2017;15:802–12. - PubMed
-
- The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye WorkShop. Ocul Surf 2007;5:75–92. 2007. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources